OPERA LTD-ADR (OPRA)

US68373M1071 - ADR

15.81  -0.08 (-0.5%)

After market: 16.4566 +0.65 (+4.09%)

Fundamental Rating

7

Overall OPRA gets a fundamental rating of 7 out of 10. We evaluated OPRA against 279 industry peers in the Software industry. OPRA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. A decent growth rate in combination with a cheap valuation! Better keep an eye on OPRA. These ratings would make OPRA suitable for value and quality investing!



7

1. Profitability

1.1 Basic Checks

In the past year OPRA was profitable.
OPRA had a positive operating cash flow in the past year.
OPRA had positive earnings in 4 of the past 5 years.
OPRA had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

OPRA has a Return On Assets of 16.49%. This is amongst the best in the industry. OPRA outperforms 97.12% of its industry peers.
OPRA has a better Return On Equity (18.09%) than 90.65% of its industry peers.
The Return On Invested Capital of OPRA (5.42%) is better than 80.94% of its industry peers.
Industry RankSector Rank
ROA 16.49%
ROE 18.09%
ROIC 5.42%
ROA(3y)4.67%
ROA(5y)7.13%
ROE(3y)5.15%
ROE(5y)7.78%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 42.61%, OPRA belongs to the best of the industry, outperforming 98.56% of the companies in the same industry.
In the last couple of years the Profit Margin of OPRA has grown nicely.
Looking at the Operating Margin, with a value of 16.19%, OPRA belongs to the top of the industry, outperforming 88.13% of the companies in the same industry.
In the last couple of years the Operating Margin of OPRA has declined.
Looking at the Gross Margin, with a value of 76.54%, OPRA is in the better half of the industry, outperforming 72.66% of the companies in the same industry.
OPRA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 16.19%
PM (TTM) 42.61%
GM 76.54%
OM growth 3Y167.01%
OM growth 5Y-10.09%
PM growth 3Y-25.11%
PM growth 5Y14.32%
GM growth 3Y-7.05%
GM growth 5Y-4.77%

8

2. Health

2.1 Basic Checks

OPRA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, OPRA has less shares outstanding
The number of shares outstanding for OPRA has been reduced compared to 5 years ago.
OPRA has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 10.53 indicates that OPRA is not in any danger for bankruptcy at the moment.
OPRA has a better Altman-Z score (10.53) than 87.77% of its industry peers.
OPRA has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
OPRA's Debt to FCF ratio of 0.13 is amongst the best of the industry. OPRA outperforms 83.81% of its industry peers.
OPRA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
OPRA's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. OPRA outperforms 65.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Altman-Z 10.53
ROIC/WACC0.69
WACC7.9%

2.3 Liquidity

OPRA has a Current Ratio of 2.56. This indicates that OPRA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of OPRA (2.56) is better than 71.94% of its industry peers.
OPRA has a Quick Ratio of 2.56. This indicates that OPRA is financially healthy and has no problem in meeting its short term obligations.
OPRA has a better Quick ratio (2.56) than 71.94% of its industry peers.
Industry RankSector Rank
Current Ratio 2.56
Quick Ratio 2.56

6

3. Growth

3.1 Past

OPRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 716.67%, which is quite impressive.
The Earnings Per Share has been growing by 42.24% on average over the past years. This is a very strong growth
The Revenue has grown by 19.90% in the past year. This is quite good.
Measured over the past years, OPRA shows a quite strong growth in Revenue. The Revenue has been growing by 19.77% on average per year.
EPS 1Y (TTM)716.67%
EPS 3Y68.46%
EPS 5Y42.24%
EPS growth Q2Q429.63%
Revenue 1Y (TTM)19.9%
Revenue growth 3Y31.05%
Revenue growth 5Y19.77%
Revenue growth Q2Q17.72%

3.2 Future

Based on estimates for the next years, OPRA will show a very negative growth in Earnings Per Share. The EPS will decrease by -20.03% on average per year.
OPRA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.50% yearly.
EPS Next Y-50.22%
EPS Next 2Y-20.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.44%
Revenue Next 2Y14.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.07, which indicates a very decent valuation of OPRA.
Based on the Price/Earnings ratio, OPRA is valued cheaper than 96.40% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.48. OPRA is valued rather cheaply when compared to this.
OPRA is valuated correctly with a Price/Forward Earnings ratio of 16.20.
Compared to the rest of the industry, the Price/Forward Earnings ratio of OPRA indicates a rather cheap valuation: OPRA is cheaper than 89.93% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of OPRA to the average of the S&P500 Index (22.79), we can say OPRA is valued slightly cheaper.
Industry RankSector Rank
PE 8.07
Fwd PE 16.2

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OPRA is valued cheaply inside the industry as 87.05% of the companies are valued more expensively.
OPRA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. OPRA is cheaper than 89.93% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.16
EV/EBITDA 16.87

4.3 Compensation for Growth

OPRA has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as OPRA's earnings are expected to decrease with -20.03% in the coming years.
PEG (NY)N/A
PEG (5Y)0.19
EPS Next 2Y-20.03%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.96%, OPRA is a good candidate for dividend investing.
OPRA's Dividend Yield is rather good when compared to the industry average which is at 11.46. OPRA pays more dividend than 97.12% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, OPRA pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.96%

5.2 History

OPRA does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

OPRA pays out 13.64% of its income as dividend. This is a sustainable payout ratio.
DP13.64%
EPS Next 2Y-20.03%
EPS Next 3YN/A

OPERA LTD-ADR

NASDAQ:OPRA (3/28/2024, 8:00:02 PM)

After market: 16.4566 +0.65 (+4.09%)

15.81

-0.08 (-0.5%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.38B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 4.96%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 8.07
Fwd PE 16.2
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.19
Profitability
Industry RankSector Rank
ROA 16.49%
ROE 18.09%
ROCE
ROIC
ROICexc
ROICexgc
OM 16.19%
PM (TTM) 42.61%
GM 76.54%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.56
Quick Ratio 2.56
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)716.67%
EPS 3Y68.46%
EPS 5Y
EPS growth Q2Q
EPS Next Y-50.22%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)19.9%
Revenue growth 3Y31.05%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y